豬瘟疫苗市場：規模、佔有率、前景、按類型、分銷管道和地區分類的機會分析（2025-2032 年）

Swine Fever Vaccine Market, by Type, by Vaccine Type, by Distribution Channel, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球豬瘟疫苗市場規模估計為 30.324 億美元，預計到 2032 年將達到 45.898 億美元，2025 年至 2032 年的複合年成長率為 6.1%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	30.324億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	6.10%	2032年價值預測	45.898億美元

數字。 2025年豬瘟疫苗市場佔有率（按地區）

豬瘟有兩種類型：古典豬瘟（CSF）和非洲豬瘟（ASF）。豬瘟（CSF）是一種高度傳染性的豬病毒性疾病。疾病的嚴重程度取決於病毒的病毒株、豬群的免疫狀態和豬的年齡。另一方面，非洲豬瘟是一種高度傳染性和致命性的病毒性疾病，會影響所有年齡層的家豬和野豬。急性非洲豬瘟和腦脊髓炎都會導致高死亡率，最嚴重的病例死亡率接近 100%。這兩種疾病也可以發展為較溫和的形式，死亡率較低。豬群死亡數量突然增加可能是豬瘟的徵兆。 ASF 和 CSF 急性期的臨床症狀包括憂鬱、發燒、食慾不振以及耳朵、鼻子和四肢出現紅色、紫色或藍色斑點。隨著病情的進展，可能會出現嘔吐和腹瀉（非洲豬瘟時為血性腹瀉），同時伴隨呼吸困難和咳嗽。這些疾病透過與受感染的豬隻直接接觸或接觸受污染的豬圈、卡車或衣物傳播。對於這兩種疾病，豬可以長期攜帶病毒，因此在疫情爆發期間必須限制豬的活動。

市場動態

政府機構加強防止豬瘟蔓延，並透過組織宣傳宣傳活動提高人們的意識，預計將在預測期內推動市場成長。例如，2022年6月，美國農業部（USDA）動植物衛生檢驗局（APHIS）宣布了新的舉措，以防止非洲豬瘟在美國的傳入和傳播。透過名為「保護我們的豬」的推廣和宣傳宣傳活動，動植物衛生檢驗局將向商業豬肉生產商、獸醫和養豬戶提供資訊和資源，以保護美國生豬數量和豬肉產業。

本研究的主要特點

本報告對全球豬瘟疫苗市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模。
它揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球豬瘟疫苗市場的主要企業概況。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員將透過用於分析全球豬瘟疫苗市場的各種策略矩陣來做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 3,032.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.10%	2032 Value Projection:	USD 4,589.8 Mn

There are two types of swine fever - Classical Swine Fever (CSF) and African Swine Fever (ASF). Classical swine fever (CSF) is an extremely contagious viral disease in pigs. The severity of the disease varies with the strain of the virus, the immune status of the herd, and the age of the pig. African swine fever, on the other hand, is a highly contagious and deadly viral disease affecting both domestic and feral swine of all ages. Acute forms of both ASF and CSF can cause high death rates, with mortality approaching 100% in the most severe form of ASF. Both diseases may also occur in milder forms with lower mortality rates. Swine fever could be considered a possibility in case of a sudden increase in deaths in a group of pigs. Clinical signs of acute forms of both ASF and CSF include depression, fever, loss of appetite, and red, purple, or blue blotching of the ears, nose, and limbs. Vomiting and diarrhea (bloody diarrhea for ASF) may occur as the disease progresses, along with breathing difficulties and coughing. The diseases spread through direct contact with infected pigs or contact with contaminated pens, trucks, or clothing. In both diseases, pigs can remain carriers of the disease for long period and therefore moving pigs during an outbreak must be restricted.

Market Dynamics

Increasing efforts by the government bodies to create awareness and prevent the spread of swine fever by organizing awareness campaigns are expected to drive the market growth over the forecast period. For instance, in June 2022, the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) announced new efforts to help prevent the introduction and spread of African swine fever in the U.S. Through an outreach and awareness campaign called "Protect Our Pigs," APHIS will support commercial pork producers, veterinarians, and pig owners with information and resources to help safeguard America's swine population and the pork industry.

Key features of the study:

This report provides an in-depth analysis of the global swine fever vaccine market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global swine fever vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global swine fever vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global swine fever vaccine market

Detailed Segmentation:

Global Swine Fever Vaccine Market, By Type:
- African Swine Fever
- Classical Swine Fever
Global Swine Fever Vaccine Market, By Vaccine Type:
- Live-Attenuated
- Chimeric (Live-attenuated or inactivated)
- Subunit or vector system based
- Replicon vaccine
Global Swine Fever Vaccine Market, By Distribution Channel:
- Public
- Private
Global Swine Fever Vaccine Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Merck & Co., Inc. (Merck Animal Health)
- Ceva
- Zoetis Services LLC
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Ltd.
- Bioveta, a.s.
- Komipharm
- EC21 Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Epidemiology
Regulatory Scenario
PEST Analysis
New Product Approval/Launch

4. Global Swine Fever Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Demand and Supply Analysis

5. Global Swine Fever Vaccine Market, By Type, 2020 - 2032, (US$ Million)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
African Swine Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Classical Swine Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Swine Fever Vaccine Market, By Vaccine Type, 2020 - 2032, (US$ Million)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Live-Attenuated
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Chimeric (Live-attenuated or inactivated)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Subunit or vector system based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Replicon vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Swine Fever Vaccine Market, By Distribution Channel, 2020 - 2032, (US$ Million)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Global Swine Fever Vaccine Market, By Region, 2020 - 2032, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, By Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Merck & Co., Inc. (Merck Animal Health)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zoetis Services LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Indian Immunologicals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bioveta, a.s.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Komipharm
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EC21 Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies